Related Experiment Video
Updated: May 12, 2026
12:40
A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors
Published on: December 7, 2014
A role for JAK2 mutations in myeloproliferative diseases
Kelly J Morgan1, D Gary Gilliland
1Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. kmorgan@rics.bwh.harvard.edu
Annual Review of Medicine
|October 9, 2007
Summary
The JAK2V617F mutation drives myeloproliferative disorders (MPDs) like polycythemia vera. This discovery emphasizes JAK-STAT signaling
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Myeloproliferative disorders (MPDs) involve clonal myeloid cell expansion.
- The JAK2V617F mutation is identified in polycythemia vera (PV), essential thrombocythemia (ET), and idiopathic myelofibrosis (IMF).
Purpose of the Study:
- To understand the role of the JAK2V617F mutation in MPDs.
- To investigate the JAK-STAT signaling pathway in myeloid differentiation.
Main Methods:
- Identification of JAK2V617F mutation in MPD patients.
- Analysis of downstream signaling pathways affected by the mutation.
- Utilizing mouse models to study the mutation's effects.
Main Results:
- The JAK2V617F mutation leads to constitutive activation of JAK2 tyrosine kinase.
- Mouse models show the mutation is sufficient for PV development.
- Further research is needed to clarify the mutation's role in ET and IMF.
Conclusions:
- The JAK2V617F mutation is a key factor in MPDs.
- JAK-STAT signaling is crucial for myeloid differentiation.
- Development of JAK2 inhibitors is a promising therapeutic strategy for MPDs.
Related Concept Videos
02:23Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:15Differentiation of Common Myeloid Progenitor Cells
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
01:20The JAK-STAT Signaling Pathway
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
03:03mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
01:28Role of Hematopoietic Growth Factors
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...